Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda

Authors: Nienke J Veldhuijzen, Sarah L Braunstein, Joseph Vyankandondera, Chantal Ingabire, Justin Ntirushwa, Evelyne Kestelyn, Coosje Tuijn, Ferdinand W Wit, Aline Umutoni, Mireille Uwineza, Tania Crucitti, Janneke HHM van de Wijgert

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

The prevalence, incidence and persistence of human papillomavirus (HPV) types in sub-Saharan Africa are not well established. The objectives of the current study are to describe (predictors of) the epidemiology of HPV among high-risk women in Kigali, Rwanda.

Methods

HIV-negative, high-risk women were seen quarterly for one year, and once in Year 2. HIV serostatus, clinical, and behavioral information were assessed at each visit, HPV types at Month 6 and Year 2, and other sexually transmitted infections (STI) at selected visits. HPV prevalence was also assessed in HIV-positive, high-risk women.

Results

Prevalence of any HPV was 47.0% in HIV-negative women (median age 25 years) compared to 72.2% in HIV-positive women (median age 27 years; OR 2.9, 95% CI 1.9-4.6). Among HIV-negative women, cumulative incidence of high-risk (HR)-HPV was 28.0% and persistence 32.0% after a mean period of 16.6 and 16.9 months, respectively. Prior Chlamydia trachomatis and Neisseria gonorrhoeae infection, concurrent low-risk (LR)-HPV infection and incident HSV-2 were associated with HR-HPV prevalence among HIV-negative women; prior C. trachomatis infection and co-infection with LR-HPV and HPV16-related HPV types with HR-HPV acquisition. HPV16-related types were the most prevalent and persistent.

Conclusions

High HPV prevalence, incidence and persistence were found among high-risk women in Kigali. HPV52 had the highest incidence; and, together with HPV33 and HPV58, were strongly associated with acquisition of other HR-HPV types in HIV-negative women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aral SO, Holmes KK: The epidemiology of STIs and their social and behavioral determinants: industrialized and developing countries. Sexually transmitted Diseases. Edited by: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH. 2008, New York: McGraw-Hill, 53-92. 4 Aral SO, Holmes KK: The epidemiology of STIs and their social and behavioral determinants: industrialized and developing countries. Sexually transmitted Diseases. Edited by: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH. 2008, New York: McGraw-Hill, 53-92. 4
2.
go back to reference Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008, 43 (4 Suppl): S5-25. S25 e21-41PubMed Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008, 43 (4 Suppl): S5-25. S25 e21-41PubMed
3.
go back to reference Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010, 202 (12): 1789-99. 10.1086/657321.CrossRefPubMed Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S: Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010, 202 (12): 1789-99. 10.1086/657321.CrossRefPubMed
4.
go back to reference Clifford GM, Goncalves MA, Franceschi S: Human papillomavirus types among women infected with HIV: a meta-analysis. Aids. 2006, 20 (18): 2337-2344. 10.1097/01.aids.0000253361.63578.14.CrossRefPubMed Clifford GM, Goncalves MA, Franceschi S: Human papillomavirus types among women infected with HIV: a meta-analysis. Aids. 2006, 20 (18): 2337-2344. 10.1097/01.aids.0000253361.63578.14.CrossRefPubMed
5.
go back to reference Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M: Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis. 2001, 28 (3): 125-130. 10.1097/00007435-200103000-00001.CrossRefPubMed Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejia LG, Garcia-Cisneros S, Hernandez-Avila M: Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis. 2001, 28 (3): 125-130. 10.1097/00007435-200103000-00001.CrossRefPubMed
6.
go back to reference Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH: Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010, 10 (12): 862-74. 10.1016/S1473-3099(10)70190-0.CrossRefPubMed Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH: Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010, 10 (12): 862-74. 10.1016/S1473-3099(10)70190-0.CrossRefPubMed
7.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 2008, 10 Lyon, France: International Agency for Research on Cancer Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 2008, 10 Lyon, France: International Agency for Research on Cancer
8.
go back to reference Braunstein Sarah, Ingabire Chantal, Kestelyn Evelyne, Uwizera Aline Umutoni, Mwamarangwe Lambert, Ntirushwa Justin, Nash Denis, Veldhuijzen Nienke, Nel Annalene, Vyankandondera Joseph, van de Wijgert Janneke: High HIV incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011, 38 (5): 384-94.CrossRef Braunstein Sarah, Ingabire Chantal, Kestelyn Evelyne, Uwizera Aline Umutoni, Mwamarangwe Lambert, Ntirushwa Justin, Nash Denis, Veldhuijzen Nienke, Nel Annalene, Vyankandondera Joseph, van de Wijgert Janneke: High HIV incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011, 38 (5): 384-94.CrossRef
9.
go back to reference Stevens MP, Garland SM, Tabrizi SN: Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods. 2008, 147 (2): 290-296. 10.1016/j.jviromet.2007.09.018.CrossRefPubMed Stevens MP, Garland SM, Tabrizi SN: Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods. 2008, 147 (2): 290-296. 10.1016/j.jviromet.2007.09.018.CrossRefPubMed
10.
go back to reference Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. Jama. 2002, 287 (16): 2114-2119. 10.1001/jama.287.16.2114.CrossRefPubMed Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. Jama. 2002, 287 (16): 2114-2119. 10.1001/jama.287.16.2114.CrossRefPubMed
11.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.CrossRefPubMed Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.CrossRefPubMed
12.
go back to reference Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6 (4): 204-10.1016/S1470-2045(05)70086-3.CrossRefPubMed Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6 (4): 204-10.1016/S1470-2045(05)70086-3.CrossRefPubMed
13.
go back to reference Schiffman M, Clifford G, Buonaguro FM: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009, 4: 8-10.1186/1750-9378-4-8.CrossRefPubMedPubMedCentral Schiffman M, Clifford G, Buonaguro FM: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009, 4: 8-10.1186/1750-9378-4-8.CrossRefPubMedPubMedCentral
14.
go back to reference Veldhuijzen NJ, Dhont N, Vyankandondera J, Gasarabwe A, Busasa R, Crucitti T, vdWijgert JHHM: Prevalence and concordance of HPV, HIV and HSV-2 in heterosexual couples in Kigali, Rwanda. Sex Transm Dis - Accepted for publication. Veldhuijzen NJ, Dhont N, Vyankandondera J, Gasarabwe A, Busasa R, Crucitti T, vdWijgert JHHM: Prevalence and concordance of HPV, HIV and HSV-2 in heterosexual couples in Kigali, Rwanda. Sex Transm Dis - Accepted for publication.
15.
go back to reference Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE: Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis. 2009, 199 (12): 1851-1861. 10.1086/599123.CrossRefPubMedPubMedCentral Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE: Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis. 2009, 199 (12): 1851-1861. 10.1086/599123.CrossRefPubMedPubMedCentral
16.
go back to reference del Amo J, Gonzalez C, Belda J, Fernandez E, Martinez R, Gomez I, Torres M, Saiz AG, Ortiz M: Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: differences by geographical origin. J Womens Health (Larchmt). 2009, 18 (12): 2057-2064. 10.1089/jwh.2008.1293.CrossRef del Amo J, Gonzalez C, Belda J, Fernandez E, Martinez R, Gomez I, Torres M, Saiz AG, Ortiz M: Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: differences by geographical origin. J Womens Health (Larchmt). 2009, 18 (12): 2057-2064. 10.1089/jwh.2008.1293.CrossRef
17.
go back to reference Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K, Depuydt CE, Claeys P, Bogers JP, Temmerman M: Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis. 2010, 10: 18-10.1186/1471-2334-10-18.CrossRefPubMedPubMedCentral Luchters SM, Vanden Broeck D, Chersich MF, Nel A, Delva W, Mandaliya K, Depuydt CE, Claeys P, Bogers JP, Temmerman M: Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis. 2010, 10: 18-10.1186/1471-2334-10-18.CrossRefPubMedPubMedCentral
19.
go back to reference Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Serwadda D, Wawer MJ, Shah KV, Gray R: Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev. 2008, 17 (6): 1300-1307. 10.1158/1055-9965.EPI-07-2678.CrossRefPubMedPubMedCentral Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Serwadda D, Wawer MJ, Shah KV, Gray R: Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev. 2008, 17 (6): 1300-1307. 10.1158/1055-9965.EPI-07-2678.CrossRefPubMedPubMedCentral
20.
go back to reference Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK: Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 2009, 36 (5): 305-311. 10.1097/OLQ.0b013e318194eb76.CrossRefPubMed Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK: Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 2009, 36 (5): 305-311. 10.1097/OLQ.0b013e318194eb76.CrossRefPubMed
21.
go back to reference Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH: HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. Aids. 2010, 24 (14): 2289-2292. 10.1097/QAD.0b013e32833cbb71.CrossRefPubMed Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH: HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. Aids. 2010, 24 (14): 2289-2292. 10.1097/QAD.0b013e32833cbb71.CrossRefPubMed
22.
go back to reference Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001, 184 (6): 682-690. 10.1086/323081.CrossRefPubMed Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001, 184 (6): 682-690. 10.1086/323081.CrossRefPubMed
23.
go back to reference De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M: Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis. 2003, 30 (2): 137-142. 10.1097/00007435-200302000-00009.CrossRefPubMed De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M: Distribution of human papillomavirus in a family planning population in nairobi, kenya. Sex Transm Dis. 2003, 30 (2): 137-142. 10.1097/00007435-200302000-00009.CrossRefPubMed
24.
go back to reference Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL: Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009, 199 (10): 1514-1524. 10.1086/598220.CrossRefPubMed Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL: Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009, 199 (10): 1514-1524. 10.1086/598220.CrossRefPubMed
25.
go back to reference McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA: Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol. 116 (3): 572-577. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA: Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol. 116 (3): 572-577.
26.
go back to reference Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER: Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005, 162 (7): 668-675. 10.1093/aje/kwi262.CrossRefPubMed Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER: Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005, 162 (7): 668-675. 10.1093/aje/kwi262.CrossRefPubMed
27.
go back to reference Verhoeven V, Baay M, Weyler J, Avonts D, Lardon F, Van Royen P, Vermorken JB: Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour. Eur J Clin Microbiol Infect Dis. 2004, 23 (9): 735-737.CrossRefPubMed Verhoeven V, Baay M, Weyler J, Avonts D, Lardon F, Van Royen P, Vermorken JB: Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour. Eur J Clin Microbiol Infect Dis. 2004, 23 (9): 735-737.CrossRefPubMed
28.
go back to reference Nielsen A, Iftner T, Munk C, Kjaer SK: Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis. 2009, 36 (10): 609-615. 10.1097/OLQ.0b013e3181a96d0e.CrossRefPubMedPubMedCentral Nielsen A, Iftner T, Munk C, Kjaer SK: Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis. 2009, 36 (10): 609-615. 10.1097/OLQ.0b013e3181a96d0e.CrossRefPubMedPubMedCentral
29.
go back to reference Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (Suppl 3): S3/52-61. Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (Suppl 3): S3/52-61.
30.
go back to reference Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL: Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect. 2009, 11 (4): 435-442. 10.1016/j.micinf.2009.01.004.CrossRefPubMed Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL: Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect. 2009, 11 (4): 435-442. 10.1016/j.micinf.2009.01.004.CrossRefPubMed
31.
go back to reference Loomis WP, Starnbach MN: T cell responses to Chlamydia trachomatis. Curr Opin Microbiol. 2002, 5 (1): 87-91. 10.1016/S1369-5274(02)00291-6.CrossRefPubMed Loomis WP, Starnbach MN: T cell responses to Chlamydia trachomatis. Curr Opin Microbiol. 2002, 5 (1): 87-91. 10.1016/S1369-5274(02)00291-6.CrossRefPubMed
32.
go back to reference Scott M, Stites DP, Moscicki AB: Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 1999, 6 (5): 751-755.PubMedPubMedCentral Scott M, Stites DP, Moscicki AB: Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 1999, 6 (5): 751-755.PubMedPubMedCentral
33.
go back to reference Moscicki AB, Schiffman M, Kjaer S, Villa LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006, 24 (Suppl 3): S3/42-51. Moscicki AB, Schiffman M, Kjaer S, Villa LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006, 24 (Suppl 3): S3/42-51.
34.
go back to reference Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, van de Wijgert JH, Oliveira RL, Diaz RS: Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS. 2010, 21 (2): 105-109. 10.1258/ijsa.2009.008436.CrossRefPubMedPubMedCentral Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, van de Wijgert JH, Oliveira RL, Diaz RS: Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS. 2010, 21 (2): 105-109. 10.1258/ijsa.2009.008436.CrossRefPubMedPubMedCentral
35.
go back to reference Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD: Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005, 191 (7): 1129-1139. 10.1086/427777.CrossRefPubMed Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD: Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005, 191 (7): 1129-1139. 10.1086/427777.CrossRefPubMed
36.
go back to reference Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS: Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008, 168 (2): 123-137. 10.1093/aje/kwn036.CrossRefPubMedPubMedCentral Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS: Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008, 168 (2): 123-137. 10.1093/aje/kwn036.CrossRefPubMedPubMedCentral
Metadata
Title
The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda
Authors
Nienke J Veldhuijzen
Sarah L Braunstein
Joseph Vyankandondera
Chantal Ingabire
Justin Ntirushwa
Evelyne Kestelyn
Coosje Tuijn
Ferdinand W Wit
Aline Umutoni
Mireille Uwineza
Tania Crucitti
Janneke HHM van de Wijgert
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-333

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.